WOW look at this move that I missed. Perfect set-up. The chart gave it away and I just missed it. Its in blue sky territory now so I am not going to chase it. But look at the chart I provided and remember this set-up. This is how charts make you green.
Chart
http://www3.stockfetcher.com/sfchart/1835639815.png
Neoprobe Corporation, a biomedical company, engages in the development and commercialization of surgical and diagnostic products. It offers gamma detection device systems that consist of hand-held detector probes and a control unit. The company's products primarily include Neo2000 gamma radiation detection equipment used in the application of sentinel lymph node biopsy to trace the lymphatic patterns in a cancer patient to evaluate potential tumor drainage and cancer spread in lymphatic tissue; and Quantix, a line of blood flow monitoring devices that are used for various diagnostic and surgical applications in the cardiac and vascular management arena. It also holds developmental and/or intellectual property rights related to two drugs that might be used in connection with gamma detection devices in cancer surgeries. These drugs under development include Lymphoseek, which traces the spread of certain solid tumor cancers; and RIGScan CR that enables surgeons to locate cancerous tissue during colorectal cancer surgeries. The company was founded in 1983 and is based in Dublin, Ohio
Shares Outstanding5: 67.48M
Float: 64.47M
% Held by Insiders1: 2.05%
% Held by Institutions1: 0.90%
Balance Sheet
Total Cash (mrq): 1.53M
Total Cash Per Share (mrq): 0.023
Total Debt (mrq): 5.41M
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 2.182
Book Value Per Share (mrq): -0.027
Revenue (ttm): 7.16M
Revenue Per Share (ttm): 0.11
Qtrly Revenue Growth (yoy): 2.30%
Gross Profit (ttm): 3.94M
NEOP - Neoprobe Corp. (OTCBB Stock)
Linear Mode
